Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
A solid close over .20 bodes well for .25-.30 next week, IMO
The day isn't over and the fun has just begun!!!
It just did!!!
I jumped in on that panic selling here yesterday.....I love panic selling!
What happened, I stepped out for a min and came back to a spike?
Preview of power hour?
RXMD RXMD RXMD RXMD RXMD
You took the words right out of my fingers
until MM"s fill those I BELIEVE large blocks we
will be here regardless..great to see thou..Every time it
looks like we are going to break they slap it back to .20 range.
Happiness is a five day chart...
Happiness is assured with a one month chart....
Post lunch narcolepsy...Traders straggling back to their desks in NY.
Nice recovery from panic selling, profit taking penny flipping sky is falling yesterday.....Power hour can go either way... I am going to let it run..
Looks like next push is on. Don't be surprised to see large orders come through that were held back as the mm's accumulated between .19 and .20.
Is this going to break up above .2 today ??
Yep, power hour could get fun
I’m looking forward to the EOD as it’s slightly boring right now. Looks like sideways action until power hour.
UPGRADED to a Whomping .30. Congrats.
https://finance.yahoo.com/news/seethruequity-issues-progressive-care-inc-131500911.html
well 35 was an easy number to calculate considering 2017 earnings. As soon as those numbers are confirmed, 03/31, we will see-seethru raise their valuation. Audited financials 03/31 should drive us close to 40 then the announcement that the pharmacy purchase has been signed sealed and delivered will be the day we see the largest pps jump in RXMDs history, so lets see if we can drive this baby to 40 before 03/31 and then watch the boom to 75-80 somewhere near the end of April.
I’m not blowing smoke. These are admittedly just my assumptions but based on established calculations after review of medical industry valuation standards.
I was right on the money, now according to seethru, 2 weeks ago when I came out with my 35 cent valuation, I am very certain these assumptions are equally as accurate.
Buyers are relentless here. EOD should be very interesting.
14 state licenses=massive expansion plans
I’m extremely excited for that
Excellent Post my friend...
RXMD OTCQB: Record Sales! Expansion! Uplisted! Small Preserved SS! 14 State Licences!
.35 price target by SeeThruEquity is great but I think we will see that very soon!!
RXMD OTCQB: Record Sales! Expansion! Uplisted! Small Preserved SS! 14 State Licences!
Share Structure
Preserved OS as compared to 2 years ago:
see---
http://www.otcmarkets.com/stock/RXMD/profile
versus historic---
https://web.archive.org/web/20151229173335/ht...MD/profile
Outstanding Shares a/o March 09, 2018 = 370,999,201(Authorized Shares 500,000,000)
Outstanding Shares a/o Dec 09, 2015 = 352,043,045 (Authorized Shares 500,000,000)
Market cap
Market cap of a company in this sector (Drugs/Pharmaceutical) see:
http://pages.stern.nyu.edu/~adamodar/New_Home...sdata.html
easily reaches 4x the P/S ratio (up to 10x*)...so for an estimated 25M revs in 2018 the RXMD pps fair market value, not even taking its constant market expansion into account, should be 30 cents in a conservative evaluation* (up to 75 cent*).
14 state licenses. Expansion to 50 states
will follow within few years meaning revenue and profit multiplication!
https://ih.advfn.com/p.php?pid=nmona&article=76101390
http://finance.yahoo.com/news/progressive-care-delivers-record-sales-175126653.html
Now Licences pending in 3 new states: Utah, Arizona, and Rhode Island https://ih.advfn.com/p.php?pid=nmona&article=76101390
SeeThruEquity Upgrades RXMD Price Target to $0.35 per Share
https://www.otcmarkets.com/stock/RXMD/news/SeeThruEquity-Upgrades-RXMD-Price-Target-to-035-per-Share?id=185746
MIAMI, March 09, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces upgraded price target to $0.35 per share from SeeThruEquity.
SeeThruEquity, a premier small and microcap research firm, released an updated analyst report today upgrading Progressive Care’s price target to $0.35 per share. The upgrade is based on recent news of the Company’s intent to acquire a pharmacy in Palm Beach County as well as increased sales, new product and technology development projects, and the acceptance Bitcoin. SeeThruEquity’s report issues analysis on the Company’s current business and releases new sales targets which provide the basis for the upgraded price target for RXMD.
https://finance.yahoo.com/news/seethruequity-issues-progressive-care-inc-131500911.html
“We are excited to see that SeeThruEquity has initiated updated coverage of the Company,” stated S. Parikh Mars, CEO. "We believe that we are executing on our objectives as we take the Progressive Care to the next level. We are humbled by the response to our story and remain focused on delivering results to our patients and shareholders alike.”
Progressive Care Executes Letter of Intent to Purchase a Pharmacy in Palm Beach County
https://www.otcmarkets.com/stock/RXMD/news/Progressive-Care-Executes-Letter-of-Intent-to-Purchase-a-Pharmacy-in-Palm-Beach-County?id=184975
MIAMI, March 02, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces that it has executed a letter of intent to purchase a pharmacy in Palm Beach County.
On March 1, 2018, the Company signed a letter of intent to purchase a pharmacy in Palm Beach County for $300,000. The Company is beginning the due diligence process with anticipated closing to occur in the second quarter of 2018. The acquisition target is located close to major highways in a 3,000 sq. ft facility. The operation has experienced staff, all applicable licenses, commensurate PBM contracts as PharmCo, LLC, and a Parata PASS 500 unit dose packaging system.
The acquisition of this pharmacy in Palm Beach County will facilitate growth by increasing the delivery radius into Martin County which includes Jupiter and Stuart. It will also decrease costs of expansion and increase prescription dispensing efficiency. The location has the adequate facility space to provide the opportunity to develop new processes for long term care services, compounded medications, and tele-pharmacy services.
In anticipation of the acquisition, the Company drew down just under $600,000 from its Chicago Ventures funding facility. These funds will allow the Company to close the transaction as well as provide working capital for additional build out and sales ramp up of the new Palm Beach location.
“We believe this is the opportunity we have been waiting for,” stated S. Parikh Mars, CEO. "We have been rapidly gaining ground in Palm Beach County and this is the missing piece to lasting success in the area. After an exhaustive search, we think that this acquisition will be just the beginning of an aggressive expansion agenda that allows the Company to reach thousands of new doctors and patients who will benefit greatly from the PharmCo pharmacy model.”
S. Parikh Mars, CEO of Progressive Care Inc., Discusses Recent RXMD News and Corporate Moves in a New Audio Interview with SmallCapVoice.com
https://www.otcmarkets.com/stock/RXMD/news/S-Parikh-Mars-CEO-of-Progressive-Care-Inc-Discusses-Recent-RXMD-News-and-Corporate-Moves-in-a-New-Audio-Interview-with-S?id=184832
AUSTIN, Texas, March 01, 2018 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, today announced that a new audio interview with the Company is now available. The interview can be heard at https://smallcapvoice.com/blog/2-28-18-smallcapvoice-interview-with-progressive-care-inc-rxmd.
S. Parikh Mars, CEO of Progressive Care Inc. called in to SmallCapVoice.com, Inc. to discuss the recent news and achievements for the Company. So far in 2018, Progressive Care announced that 23,000 prescriptions were filled during the month of January, generating $1.8 million in net revenues. That is record for the Company and up 34% from the same month in 2017. RXMD is also proud of the work they are accomplishing with Mass Ventures Corp, a Florida company, who has significantly enhanced the digital presence and technology solutions for the company and all subsidiaries. Other important achievements include the expansion into Palm Beach County and the news that its retail pharmacy will officially begin accepting Bitcoin payments.
In the interview, Ms. Mars was asked what she was excited about in 2018 for her Company and she stated, “I think the coolest thing that I am most excited about is our Telepharmacy platform. While it might be hard for someone who has not seen the software or hasn’t interacted with a kiosk yet to imagine how it works, essentially it allows the patient to go to the doctor, come out with a prescription, visit a convenient kiosk, interact directly with a pharmacy technician on the screen, and speak right to a pharmacist remotely and in real time. There is a face to face interaction with a pharmacist to handle any question or concern the patient has without ever having to visit the pharmacy and wait in line. The medication is then delivered directly to patient’s home. All of this is safe, secured through the software, and HIPAA compliant.”
Progressive Care to Accept Bitcoin for its Pharmacy Unit
https://www.otcmarkets.com/stock/RXMD/news/Progressive-Care-to-Accept-Bitcoin-for-its-Pharmacy-Unit?id=183568
MIAMI, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces that its retail pharmacy will officially begin accepting Bitcoin payments. Customers that choose to pay using Bitcoin will undergo a similar payment process as customers using credit cards or online payment processing platforms such as Paypal.
PharmCo, LLC will use external payment providers, such as BitPay, to process all Bitcoin payments. BitPay compliance analysts approved the pharmacy for Tier 2 volume processing limit on February 14, 2018. Tier 2 provides daily cash settlements in USD and has a $500,000 annual limit. This will allow the pharmacy to reach more customers who are increasingly using cryptocurrencies for daily purchases. Mass Ventures Corp will develop and integrate Bitcoin processing into the Company’s e-commerce platform for seamless ease of use.
“We are committed to evolving the pharmacy both operationally and technologically,” stated S. Parikh Mars, CEO. "PharmCo will be one of the few pharmacies in the country enabling systems for cryptocurrency acceptance. The main purpose of accepting Bitcoin payments is to provide value to the end customer by aligning ourselves with the current lifestyles of a large and rapidly growing demographic using this cryptocurrency within the community.”
Progressive Care Breaks Record with Over 23,000 Prescriptions Filled in January 2018
https://www.otcmarkets.com/stock/RXMD/news/Progressive-Care-Breaks-Record-with-Over-23000-Prescriptions-Filled-in-January-2018?id=183298
MIAMI, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces record breaking month of January 2018.
PharmCo, LLC filled over 23,000 prescriptions during the month of January, generating $1.8 million in net revenues. Prescriptions filled increased by 34% compared to the same month last year and by 10% over the last record breaking month in October 2017. Revenues increased by approximately 9% as compared to January 2017. The company also filled over $450,000 worth of prescriptions (not included in Net Revenues) for 340B entities in January, generating fees to the pharmacy of just over $20,000. Current growth has been driven by expansion into Palm Beach County, the digital marketing campaign with Mass Ventures Corp, proficiency of medication therapy management and adherence programs, and the visibility of the pharmacy’s 5 star service rating among physicians and patients throughout South Florida.
“We are thrilled about the fast start to 2018,” stated S. Parikh Mars, CEO. "We are just beginning to see the results from the groundwork we laid in 2017. Over the past 12 months, we have strategically positioned ourselves to take advantage of the changing trends in the healthcare industry. Today, more physicians than ever before are recognizing the impact PharmCo and its model has on their bottom line. They are increasingly seeking out our services to improve patient outcomes and increase profitability.”
Common Shares Issued and Outstanding:
As of February 13, 2018 the number shares of common stock issued and outstanding stood at 365,408,769 shares. This amount is net of the number of shares owned by PharmCo, LLC of 1,718,000. The Company has fully paid off its first installment from Chicago Venture Partners. The Company paid approximately $130,000 in cash and $150,000 in stock. Total shares issued to Chicago Venture Partners was 19,863,662.
Progressive Care Engages Mass Ventures Corp for Digital and Technology Solutions
https://ih.advfn.com/p.php?pid=nmona&article=76552057
MIAMI, January 25, 2018 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces that it has engaged Mass Ventures Corp, a Florida company, to enhance the digital presence and technology solutions of the company and all subsidiaries.
Progressive Care engages Mass Ventures Corp to initiate a digital marketing campaign for both Progressive Care and PharmCo, LLC. The principle of Mass Ventures will be located on-site to provide real-time updates as needed. The campaign consists of many features including, but not limited to, website upgrades, enhanced and updated content, blog posting, social media development, press release distribution, search engine optimization, etc. Mass Ventures is also in the process of developing the Company’s e-commerce platform which will be capable of accepting all payment methods including cryptocurrencies such as Bitcoin. These measures are taken to coincide with the overall technological development of the company to improve the efficacy and exposure of the Company’s public information and virtual interaction with its shareholders and customers.
“The Mass Ventures Corp team has worked with us for over 5 years,” stated S. Parikh Mars, CEO. “We are excited to bring them on-site and begin a transformation of our online presence, as well as creating technology solutions that will modernize all areas of our enterprise. We believe that efforts in this area will make a difference in how we set ourselves apart as a company of the future. This will change how our shareholders and customers perceive and interact with us. Already, we are seeing the impact this project has had on our customer engagement and market awareness.”
“Progressive Care and PharmCo, LLC are ripe for exponential growth and success.” says Marcello Jaspan, owner and operator at MVC . “We are thrilled about the opportunity to serve such an amazing group and to work closely to create engagement and social buzz. On the technical side, we have infinite possibilities for expansion. We started with the launch of Tele-Pharmco, and we will soon have many Apps for customers and internal logistics alike. We will have goodies for everyone coming real soon, all aimed at making everyone’s lives easier and more enjoyable.”
Progressive Care Continues to Break Records with Over $20 Million in Sales
http://www.otcmarkets.com/stock/RXMD/news/Progressive-Care-Continues-to-Break-Records-with-Over--20-Million-in-Sales?id=180050&b=y
MIAMI, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), through its subsidiary PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management, announces over $20 million in net revenues on approximately 225,000 prescriptions filled in 2017.
PharmCo, LLC filled over 19,500 prescriptions during the month of December, generating approximately $1.6 million in net revenues. Prescriptions filled increased by approximately 8% over the same month last year. The company also filled over $360,000 (not included in net revenues) worth of prescriptions for 340B entities in December, generating fees to the pharmacy of over $15,000.
The company has been successful in breaking records in 2017. The company announced over $20 million in net revenues, an 11% increase over 2016. The company is expecting to achieve increased growth through 2018 as well as continued reporting of strong operational and financial performance. These all-time high sales figures indicate a positive outlook for the company into the coming year.
During the Earnings Call held on November 14, 2017, S. Parikh Mars (CEO), discussed avenues of expansion and advancement for the company during the coming year. In addition to record breaking sales, the company has been successful in its efforts to upgrade its OTCMarkets listing tier to OTCQB. The sales reported are recognized from diversified revenue streams and ongoing development of the Company’s portfolio of healthcare services. Innovation is also a factor as the company launched numerous new and exciting programs in 2017, such as its tele-pharmacy platform.
“2017 was a year of accomplishment and we are proud of all that this company has achieved,” stated S. Parikh Mars, CEO. "Reaching $20 million in sales was a challenge this year given the ever changing climate in the healthcare industry. However, we have elevated our level of service and secured our footing for continued growth and expansion in 2018. We now embark on a new set of ambitious goals for the year. Our hard work and dedication will continue to drive us as we prepare for many possible and exciting outcomes.”
S. Parikh Mars, CEO of Progressive Care Inc., Provides Progress Report and Outlook for Investors in New Audio Interview at SmallCapVoice.com
www.otcmarkets.com/stock/RXMD/news/S--Parikh-Mars--CEO-of-Progressive-Care-Inc---Provides-Progress-Report-and-Outlook-for-Investors-in-New-Audio-Interview-at-SmallCapVoice-com?id=179764&b=y
AUSTIN, Texas, Jan. 08, 2018 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and Progressive Care Inc. (The “Company”) (OTCQB:RXMD), today announced that a new audio interview with the Company is now available. The interview can be heard at https://smallcapvoice.com/blog/1-4-18-smallcapvoice-interview-with-progressive-care-inc-rxmd.
S. Parikh Mars, CEO, called in to SmallCapVoice.com to discuss the business model and markets for the company, the recent news and milestones achieved in 2017, what investors can expect from the Company in 2018, and more. In December 2017 the Company announced over $1.7 million in net revenues on nearly 21,000 prescriptions filled in November 2017. A major corporate milestone was also achieved in December as the Company was listed on a higher exchange, the OTC QB.
In the interview, Ms. Mars stated, “As experts in the pharmacy space, we market ourselves primarily to healthcare providers who are looking for pharmacies who they can recommend to their patients knowing that their patients will be well taken care of. We understand that the leading cause of ER visits and readmissions stems from a failure to adhere to a medication regiment and that affects healthcare costs and bottom lines across the healthcare system. By managing this risk, we deliver approved health outcomes to patient and lower health care costs to providers and insurance companies. This has allowed us to develop a solid reputation as a five-star pharmacy which has been a primary driver of increased sales and growth.”
For the video version of this interview, please visit https://youtu.be/oaylHtfuMgc.
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://smallcapvoice.com/blog/the-small-cap-daily-small-cap-newsletter/.
Progressive Care Announces Uplist to OTCQB
http://www.otcmarkets.com/stock/RXMD/news/Progressive-Care-Announces-Uplist-to-OTCQB?id=177041&b=y
MIAMI, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTC PINK:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management, announces OTC Markets approval for uplist to OTCQB effective December 5, 2017.
As of Tuesday, December 5 2017, Progressive Care will trade on OTCQB Venture Market for early stage and developing U.S. and international companies. The Company received approval for the change in listing tier after supplying OTC Markets with all mandatory documents and information, adding independent board members, adding a majority independent audit committee, and providing audited financial statements for 2016. Investors can still find Real-Time quotes and market information for the Company on www.otcmarkets.com (OTCQB:RXMD).
“We have been preparing for this moment since the requirements for OTCQB were announced earlier this year,” stated S. Parikh Mars, CEO. “We continue to take pride in delivering current and complete information to the public and we believe that the change in listing tier will bring our company to a fresh audience and a new level of investor confidence. We are excited to begin rounding out the year on such a positive note.”
Progressive Care Reports Stellar Third Quarter Results
https://ih.advfn.com/p.php?pid=nmona&article=76101390
MIAMI, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Progressive Care Inc. (RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management, announces financial results for the third quarter and provides updates on the Company’s strategies.
The company dispensed a total of 163,000 prescriptions during the nine months ended September 30, 2017, an increase of 2.5%. Revenues for the third quarter increased 5% to just over $5.1 million. Revenues increased 14% for the nine months ended September 30, 2017 to over $15 million. The Company continues to grow its patient base by marketing to doctors’ offices and clinics who refer their patients to the pharmacy. Healthcare providers are increasingly recommending PharmCo because of its high standards of patient care and attention to performance measurements and their implications.
Operating income decreased by approximately $250,000 in 2017 as compared to 2016. Third quarter operating income was negatively impacted primarily by increases in DIR fees. “DIR” stands for “direct and indirect remuneration” and was initially a term coined by the Centers for Medicare and Medicaid Services (CMS) related to the Medicare Part D benefit to address price concessions that would ultimately impact the gross prescription drug costs of Medicare Part D plans that were not captured at the point of sale.
Today, DIR fees are effectively PBM clawbacks of reimbursements based on factors that vary from plan to plan. These fees lack transparency and are extremely difficult to predict and accrue. DIR fees are often applied retroactively, which has caused the cost of DIR fees to be nearly 200% higher than in the second quarter of the year. DIR fees through September 30, 2017 was over $300,000, over half of which was incurred in the third quarter. Some PBMs may reduce or return DIR Fees based on the performance of the pharmacy within their network.
Q & A Updates
New States – The Company has renewed its efforts to acquire state licenses. PharmCo has licenses pending in three new states: Utah, Arizona, and Rhode Island.
Investor Relations – First Look Equities is tasked with PR distribution. Their distribution platform is designed to increase the number of readers of the Company’s press releases and information which would ultimately have a positive impact on trading volume and shareholder value. The Company is also looking to recruit its own in-house IR team that would work to increase shareholder value.
TelePharmacy – The Company is working on a proprietary platform that would deliver technician or pharmacist consultation services direct to patients or healthcare providers through a secure digital live stream. This platform is currently being tested in Century Village of Pembroke Pines and has had an impact on company recognition, brand loyalty, and prescription processing efficiency.
Progressive Care (RXMD) through its 100% owned subsidiaries PharmCo and Smart Medical Alliance is quickly becoming one of South Florida's leading health services organisations
New appointments to the Board of Directors among those Oleg Firer. Oleg Firer is regarded as one of Florida most successful businessman and a Wall Street heavy hitter. He takes companies like Progressive Care (RXMD) to the next level. Check out these awesome recognitions he has received!
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=135023809
Progressive Care (RXMD) has been awarded a 5-Star Rating based on the ratings provided by various insurance carriers. Rated among the top 10% of all Pharmaceutic Benefit Networks in the NATION Progressive Care (RXMD) is right there with the big players and a major buyout target.
The ScriptPro Pharmacy Automation System is online and fully operational
http://ih.advfn.com/p.php?pid=nmona&article=72964854&symbol=RXMD
The Company will ship medications from its Florida facility to other states
http://www.streetinsider.com/Press+Releases/Progressive+Care%3A+PharmCo+Receives+New+York+Pharmacy+License/11508843.html
Love it! those mindless sheep are gone and serious investors moved in on the opportunity. an excellent reaction by smart investors
Yeses its better they get out as soon as possible while we have momentum. ..I thank them...
Now that the weak sheep crew is gone, I see a heavy volume buying power hour today!
Yeses I saw some big blocks yesterday eod
pochemunyet
Long term you will make more money here. A company that has proven they
know how to grow and unlike IDCC who needs license renewals and court
cases all RXMD does it just keep taking care of patients and selling
prescriptions. Population is getting older and the need will grow.
As always service wins customers. That and convience is a hard thing
to beat. The growth potential here is unlimited for years to come.
JMO
Mickey
Look at how many more followers we have gained. Word is starting to spread about this undervalued gem!!!
Good call sir. Good for all you guys. Good luck
I agree with this blanket statement! LOL
RXMD GREEN!
Big investors are showing up and buying....
I like it!
Holding Strong
RXMD!
Well except those that sold yesterday. ..I hope they don't lose on their next flip...I'm good here....
Hey, Mickey. Had to move a bit from IDCC to this stock this week.
PARTY @ THESERB'S once we go over 1 buck chuck and stay.
When is next earnings report?
Hopefully we will also get a finalization on the Palm Beach acquisition,
and news on more openings in some of the other states. I hope they
start opening stores all over the country rather quickly as I am sure
venture capitalist will be glad to finance a thriving business.
JMO
Mickey
looking AWESOME...TRAIN LEAVING We don't do 'NO ONE LEFT BEHIND"
Bids are Fn stacked above .20!! Ah well... They were... Let's do this!!!
Hell I'm in Central time zone there is time for 21-22 before lunch!!
RXMD..
Anything under .50 is still cheapie imo.
RXMD is a NASDAQ stock clothing in OTC MARKET ATM!
In 2-5 years...
RXMD true values will reveal itself.
glta.
Enjoy the RISE LONGS!
weeeeee nice reset
These $500 buy and sells are laughable!
We are still golden!
RXMD!
mm's continue to fill orders for large buyers. All that red just accumulated into a 390K buy at .20. Up she goes. This is the reason retail cannot get large quantities.
Before or after lunch?
Flipped once, bull$%@# day trade pattern that's why
Followers
|
745
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
194665
|
Created
|
01/09/11
|
Type
|
Free
|
Moderators gedi8 Truth022809 stockforce TrackDude MrMike241 |
Progressive Care Gains SEC Reporting Status
See on website
Miami, FL – April 12, 2022 – Globe Newswire via NewMediaWire – Progressive Care, Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, today announced that, effective April 11, 2022, its Registration Statement on Form 10 filed with the U.S. Securities and Exchange (the “SEC”) to register its shares of common stock under Section 12(g) of the Securities Exchange Act of 1934 (the “Exchange Act”) became automatically effective.
The effective Form 10 obligates the Company to file Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, in addition to complying with all other obligations under the Exchange Act. In addition, management and certain shareholders are subject to the beneficial ownership reporting requirements of Section 13 and 16 of the Exchange Act.
Alan Jay Weisberg, Chairman and Chief Executive Officer of the Company said, “For me, it was always important to have the Company become fully reporting with the SEC. I know how critical it is for individual and institutional investors to have the Company file its financial reports with the SEC as it provides a higher level of confidence in the information reported by the Company and a superior level of transparency. I believe that the Company’s compliance with the Exchange Act will ultimately help drive shareholder value and enable us to access higher quality institutional capital. We remain committed to strong corporate governance and steadfast in pursuit of our journey to Nasdaq.”
To view the Form 10 filling, please click:
https://www.sec.gov/Archives/edgar/data/0001402945/000149315222009357/form10-12ga.htm
Key Financial Highlights for Year Ended December 31, 2021
• Revenue at $38.9 million
- COVID-19 testing revenue of approximately $4.3 million
- ClearMetrX TPA and pharmacy dispensing revenue related to 340B earned $2.8 million on total billings of $19 million
• Gross margin increased to 26% in 2021, from 23% in 2020
• EBITDA increased to $167,000 in 2021 from $7,000 in 2020
• Cash balance of $1.4 million as of December 31, 2021
Business Highlights for the Year Ended December 31, 2021
• Re-implemented upgraded pharmacy software system
• Expanded COVID-19 business into corporate-focused services and institutional clients
• Strengthened reputation in the 340B sector by adding eight new contracts
• Filed initial S-1 registration statement
• Submitted application for uplisting to Nasdaq
Q4 2021 Reflected a Positive Bounce Back in Business
• Increase of 10% in prescription revenue to $8.9 million in the fourth quarter of 2021, from $8.1 million in the third quarter of 2021
• Increase of 8% in prescriptions filled to 114,000 in the fourth quarter of 2021, from 106,000 in the third quarter of 2021
PRODUCTS AND SERVICES
Advances in HIV/AIDS treatment has greatly increased the ability of those suffering from the disease to manage their symptoms and live longer, healthier lives. Effective management of the disease begins with taking the right medications with the right dose at the right times. For those in the HIV/AIDS community, adhering to the very strict dietary and medicinal requirements can be extremely difficult. Normal activities are often interrupted and sometimes prevented by the struggle to be in compliance.
PharmCo wants to ease this burden on those impacted by this life altering disease. We aim to make compliance with prescription regiments as easy as possible. By understanding the sensitive nature of HIV/AIDS and the needs of those afflicted, PharmCo provides the following services to patients with these special needs:
1. Confidential packaging
2. Packaging tailored to suit a patient's individual life style
3. Free delivery from a variety of sources including PharmCo's proprietary delivery fleet
4. A staff that is well trained in acute illnesses, who understands the patient's needs and
concerns
5. 24 hour emergency support
6. Timely availability of specialty medications due to our extensive inventory
7. Access to newly developed medications
PharmCo is a fully accredited DME supplier. In November 2010, as part of Medicare's competitive bidding, PharmCo was awarded a three year contract to supply hospital beds, oxygen supplies, power wheelchairs, scooters, walkers, and other related equipment and accessories in South Florida. PharmCo carries an extensive inventory of equipment and accessories with most special requests being honored with same day or next day delivery. The company offers both sales and rentals with size, color, style, and brand options available on the majority of products. Most importantly, the staff is knowledgeable, helpful and dedicated to providing superior customer service.
PharmCo offers home service and maintenance, defective product replacements, and free home installation and instruction.
PharmCo's institutional clients have come to depend on the company's proven accuracy, dispensing methods, and immediate response time. With PharmCo compliance and efficiency assistance, long term care institutions are able to provide the highest level of continued care to their patients. PharmCo provides purchasing, repackaging and dispensing of both prescription and non-prescription pharmaceutical products. PharmCo utilizes a unit-of-dose packaging system as opposed to traditional vials used for its retail customers. This method of distribution improves control and patient compliance with recommended drug therapy by increasing the timeliness and accuracy of medication dispensing. PharmCo also provides computerized maintenance of patient prescription histories, third party billing and consultant pharmacist services. Its consulting services consist primarily of evaluation of monthly patient drug therapy and monitoring the institution’s drug distribution system.
Long term care institutions can count on PharmCo for the following services:
1. On time, same day deliveries available twice a day with 24 hour emergency support
2. Language assistance in English, Spanish, French, Creole, Portuguese, Russian, and Hebrew
3. Unit-dose packaging options tailored the facility's needs
4. Prescription data accuracy
5. Extensive medication and DME inventory
6. Access to OTC medications, nutritional products and personal hygiene items
7. Provision and review of medication carts
8. Monthly pharmacy consultations- drug interactions, redundant therapies, side effects, etc.
9. Compliance updates and consultations
10. Staff Training
11. Exceptional customer service.
Toll Free: 888-919-7411 Phone: 305-919-7399 Fax: 305-919-7424
HOURS
Monday- Thursday 8:30 AM - 6:30 PM
Friday 8:30 AM - 6:00 PM
Saturday 11:00 AM - 4:00 PM
PharmCo currently services: Miami-Dade, Broward, Palm Beach, Martin, and St. Lucie Counties.
Progressive Care Reports Full Year 2021 Financial Results Highlighted by $38.9 Million in RevenueGLOBENEWSWIRE – 11:16 AM ET 03/29/2022 |
Progressive Care’s PharmcoRx Gains Status as Approved COVID-19 Test Vendor in the U.S. for Travel to Beijing Winter Olympic Games in ChinaGLOBENEWSWIRE – 7:00 AM ET 02/02/2022
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |